101 related articles for article (PubMed ID: 8585424)
1. Extracellular matrix synthesized by clonal osteogenic cells is osteoinductive in vivo and in vitro: role of transforming growth factor-beta 1 in osteoblast cell-matrix interaction.
Kirk MD; Kahn AJ
J Bone Miner Res; 1995 Aug; 10(8):1203-8. PubMed ID: 8585424
[TBL] [Abstract][Full Text] [Related]
2. The role of type I collagen in the regulation of the osteoblast phenotype.
Shi S; Kirk M; Kahn AJ
J Bone Miner Res; 1996 Aug; 11(8):1139-45. PubMed ID: 8854250
[TBL] [Abstract][Full Text] [Related]
3. Vgr-1/BMP-6 induces osteoblastic differentiation of pluripotential mesenchymal cells.
Gitelman SE; Kirk M; Ye JQ; Filvaroff EH; Kahn AJ; Derynck R
Cell Growth Differ; 1995 Jul; 6(7):827-36. PubMed ID: 7547504
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of retinoic acid and growth factors on osteoblastic markers and CD10/NEP activity in stromal-derived osteoblasts.
Benayahu D; Fried A; Shamay A; Cunningham N; Blumberg S; Wientroub S
J Cell Biochem; 1994 Sep; 56(1):62-73. PubMed ID: 7528753
[TBL] [Abstract][Full Text] [Related]
5. Modulation of expression and cell surface binding of members of the transforming growth factor-beta superfamily during retinoic acid-induced osteoblastic differentiation of multipotential mesenchymal cells.
Gazit D; Ebner R; Kahn AJ; Derynck R
Mol Endocrinol; 1993 Feb; 7(2):189-98. PubMed ID: 8385738
[TBL] [Abstract][Full Text] [Related]
6. A recombinant human TGF-beta1 fusion protein with collagen-binding domain promotes migration, growth, and differentiation of bone marrow mesenchymal cells.
Andrades JA; Han B; Becerra J; Sorgente N; Hall FL; Nimni ME
Exp Cell Res; 1999 Aug; 250(2):485-98. PubMed ID: 10413602
[TBL] [Abstract][Full Text] [Related]
7. Cell substratum modulates responses of preosteoblasts to retinoic acid.
Traianedes K; Ng KW; Martin TJ; Findlay DM
J Cell Physiol; 1993 Nov; 157(2):243-52. PubMed ID: 8227157
[TBL] [Abstract][Full Text] [Related]
8. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
[TBL] [Abstract][Full Text] [Related]
9. Dependence of mesenchymal cell responses on duration of exposure to bone morphogenetic protein-2 in vitro.
Puleo DA
J Cell Physiol; 1997 Oct; 173(1):93-101. PubMed ID: 9326453
[TBL] [Abstract][Full Text] [Related]
10. TGF beta alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype.
Breen EC; Ignotz RA; McCabe L; Stein JL; Stein GS; Lian JB
J Cell Physiol; 1994 Aug; 160(2):323-35. PubMed ID: 8040190
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitro.
Hiraki Y; Inoue H; Shigeno C; Sanma Y; Bentz H; Rosen DM; Asada A; Suzuki F
J Bone Miner Res; 1991 Dec; 6(12):1373-85. PubMed ID: 1665281
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of transforming growth factor-beta 1 and bone morphogenetic protein 4 on gene expression and differentiated function of preosteoblasts.
Zhou H; Hammonds RG; Findlay DM; Martin TJ; Ng KW
J Cell Physiol; 1993 Apr; 155(1):112-9. PubMed ID: 8385674
[TBL] [Abstract][Full Text] [Related]
13. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
Gutierrez J; Osses N; Brandan E
J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
[TBL] [Abstract][Full Text] [Related]
14. Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development.
Quarles LD; Yohay DA; Lever LW; Caton R; Wenstrup RJ
J Bone Miner Res; 1992 Jun; 7(6):683-92. PubMed ID: 1414487
[TBL] [Abstract][Full Text] [Related]
15. Pulsed electromagnetic field stimulation of MG63 osteoblast-like cells affects differentiation and local factor production.
Lohmann CH; Schwartz Z; Liu Y; Guerkov H; Dean DD; Simon B; Boyan BD
J Orthop Res; 2000 Jul; 18(4):637-46. PubMed ID: 11052501
[TBL] [Abstract][Full Text] [Related]
16. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts.
Harris SE; Bonewald LF; Harris MA; Sabatini M; Dallas S; Feng JQ; Ghosh-Choudhury N; Wozney J; Mundy GR
J Bone Miner Res; 1994 Jun; 9(6):855-63. PubMed ID: 8079661
[TBL] [Abstract][Full Text] [Related]
17. Effects of transforming growth factor-beta 1 on murine clonal osteoblastic cells (MC3T3-E1).
Okawa M; Hakeda Y; Wakatsuki N; Katoh Y; Higashino K; Kumegawa M
Meikai Daigaku Shigaku Zasshi; 1990; 19(3):310-22. PubMed ID: 2134892
[TBL] [Abstract][Full Text] [Related]
18. Mouse embryo-derived NIH3T3 fibroblasts adopt an osteoblast-like phenotype when treated with 1alpha,25-dihydroxyvitamin D(3) and dexamethasone in vitro.
Shui C; Scutt AM
J Cell Physiol; 2002 Nov; 193(2):164-72. PubMed ID: 12384993
[TBL] [Abstract][Full Text] [Related]
19. Gene expression in osteoblastic cells.
Rodan GA; Noda M
Crit Rev Eukaryot Gene Expr; 1991; 1(2):85-98. PubMed ID: 1802105
[TBL] [Abstract][Full Text] [Related]
20. Wnt inhibitory factor (WIF)-1 inhibits osteoblastic differentiation in mouse embryonic mesenchymal cells.
Cho SW; Yang JY; Sun HJ; Jung JY; Her SJ; Cho HY; Choi HJ; Kim SW; Kim SY; Shin CS
Bone; 2009 Jun; 44(6):1069-77. PubMed ID: 19254785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
